ICCC
ImmuCell Corporation Achieves Record-Breaking $10 Million Revenue Quarter, Shows Confidence in Strategic Focus on Calf Scours Market
On May 15, 2026, ImmuCell Corporation hosted a conference call to discuss its unaudited first quarter 2026 financial results. The company reported a significant milestone, achieving its first-ever $10 million revenue quarter, marking an exciting achievement for the commercial team and manufacturing team. The $10.4 million in product sales